LENZ Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: LENZ Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2024.
LENZ Therapeutics, Inc. Assets for the quarter ending June 30, 2024 was $203M, a 29.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$203M	-$84.4M	-29.4%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$217M	-$92.7M	-29.9%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$70.4M	-$252M	-78.1%	Dec 31, 2023	10-Q	2024-08-14
Q3 2023	$266M	-$68.6M	-20.5%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$287M	-$66.7M	-18.9%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$310M	-$68.6M	-18.1%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$322M	-$80.1M	-19.9%	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$335M	-$81.3M	-19.5%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$354M	-$33.3M	-8.61%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$379M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$402M	+$379M	+1682%	Dec 31, 2021	10-K	2023-03-20
Q3 2021	$416M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$387M			Jun 30, 2021	10-Q	2021-08-12
Q4 2020	$22.6M			Dec 31, 2020	10-K	2022-03-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.